{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:10:59Z","timestamp":1785906659624,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS03234"],"award-info":[{"award-number":["R01HS03234"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018383","name":"Northern Ireland Connected Health Innovation Centre","doi-asserted-by":"publisher","award":["R01AI152183"],"award-info":[{"award-number":["R01AI152183"]}],"id":[{"id":"10.13039\/100018383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018383","name":"Northern Ireland Connected Health Innovation Centre","doi-asserted-by":"publisher","award":["R01HG010863"],"award-info":[{"award-number":["R01HG010863"]}],"id":[{"id":"10.13039\/100018383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI181927"],"award-info":[{"award-number":["U01AI181927"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT11234999"],"award-info":[{"award-number":["GNT11234999"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH K12"],"award-info":[{"award-number":["NIH K12"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["GNT2028952"],"award-info":[{"award-number":["GNT2028952"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["U01AI154659"],"award-info":[{"award-number":["U01AI154659"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["R13AR074889"],"award-info":[{"award-number":["R13AR074889"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007208","name":"Vanderbilt Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007208","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaip.2025.07.039","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:58:03Z","timestamp":1753977483000},"page":"3243-3253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anaphylaxis to Penicillin: Harvesting Insights From the Food and Drug Administration\u2019s Adverse Event Reporting System"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6558-2705","authenticated-orcid":false,"given":"Ami P.","family":"Belmont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Milan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dodie","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Martin-Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Cosby A.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.07.039_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.039_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2025.07.039_bib3","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.jaip.2024.08.053","article-title":"Examining the utility of penicillin allergy clinical decision rules: how low will you go?","volume":"12","author":"Vogrin","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaip.2019.11.035","article-title":"Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: a retrospective population-based study","volume":"8","author":"Liang","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib5","first-page":"1308","article-title":"Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever","volume":"337","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.07.039_bib6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jac\/dkm315","article-title":"Results of a UK survey of fatal anaphylaxis after oral amoxicillin","volume":"60","author":"Lee","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2025.07.039_bib7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Roger","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.039_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/jama.1953.03690020006002","article-title":"Penicillin anaphylaxis, nonfatal and fatal reactions","volume":"152","author":"Feinberg","year":"1953","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jaip.2025.07.039_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jamainternmed.2023.1572","article-title":"Evaluating the PEN-FAST Clinical Decision-making Tool to enhance penicillin allergy delabeling","volume":"183","author":"Su","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2025.07.039_bib11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2025.07.039_bib12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jaip.2024.03.013","article-title":"Unraveling cephalosporin-associated anaphylaxis: a comprehensive analysis using FDA Adverse Event Reporting System data","volume":"12","author":"Shah","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23834-1","article-title":"A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib","volume":"12","author":"Yin","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2025.07.039_bib14","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.jaip.2021.05.008","article-title":"Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System","volume":"9","author":"Bluestein","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40360-023-00710-w","article-title":"Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022","volume":"24","author":"Huang","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jaip.2025.07.039_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101967","article-title":"Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database","volume":"59","author":"Zhou","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaip.2025.07.039_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.07.039_bib18","article-title":"Characterization of demographics, drug latency, and mortality of severe cutaneous adverse reactions in an FDA pharmacovigilance database","author":"Mukherjee","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.jaip.2025.07.039_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jaip.2020.07.056","article-title":"Testing strategies and predictors for evaluating immediate and delayed reactions to cephalosporins","volume":"9","author":"Stone","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/all.15508","article-title":"Resensitization in suspected penicillin allergy","volume":"78","author":"Do\u00f1a","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.07.039_bib21","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jaip.2020.02.025","article-title":"Tolerability of cefazolin and ceftibuten in patients with IgE-mediated aminopenicillin allergy","volume":"8","author":"Romano","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib22","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.jaip.2022.08.045","article-title":"The combined use of chronological and morphological criteria in the evaluation of immediate penicillin reactions: evidence from a large study","volume":"10","author":"Romano","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaip.2013.11.006","article-title":"Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis","volume":"2","author":"Romano","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib24","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.1993.03510200062033","article-title":"Clinical experience with penicillin skin testing in a large inner-city STD clinic","volume":"270","author":"Gadde","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2025.07.039_bib25","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.jaip.2019.02.040","article-title":"Penicillin allergy evaluation: a prospective, multicenter, open-label evaluation of a comprehensive penicillin skin test kit","volume":"7","author":"Solensky","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib26","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.jaip.2023.05.027","article-title":"Cephalosporins can be safely administered to patients with verified penicillin allergy","volume":"11","author":"Belmont","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib27","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaci.2005.02.026","article-title":"Importance of mixture of minor determinants and benzylpenicilloyl poly-l-lysine skin testing in the diagnosis of \u03b2-lactam allergy","volume":"115","author":"Bousquet","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.039_bib28","first-page":"257","article-title":"Assessment of a new brand of determinants for skin testing in a large group of patients with suspected beta-lactam allergy","volume":"17","author":"Matheu","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.039_bib29","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.jaip.2020.12.051","article-title":"Piperacillin-tazobactam hypersensitivity: a large, multicenter analysis","volume":"9","author":"Casimir-Brown","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.039_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2125.1992.tb05647.x","article-title":"Idiosyncratic drug reactions: a mechanistic evaluation of risk factors","volume":"34","author":"Park","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2025.07.039_bib31","first-page":"159","article-title":"Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock","volume":"38","author":"Idsoe","year":"1968","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaip.2025.07.039_bib32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jamainternmed.2024.4606","article-title":"Reaction risk to direct penicillin challenges: a systematic review and meta-analysis","volume":"184","author":"Blumenthal","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2025.07.039_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825007299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825007299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:06:59Z","timestamp":1778893619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825007299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213219825007299"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.039","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anaphylaxis to Penicillin: Harvesting Insights From the Food and Drug Administration\u2019s Adverse Event Reporting System","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}